Key statistics dashboard for iSpecimen Inc. (ISPC). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.
iSpecimen Inc. operates a sophisticated technological platform that effectively bridges the gap between life science researchers and crucial human biological materials. Its proprietary cloud-based system empowers scientists to efficiently locate and access a vast array of biospecimens—such as biofluids, tissues, and living cells—as well as connect with potential study subjects, all sourced from a global network of healthcare providers, including hospitals, laboratories, bioba...
Stock Data
| Price | $1.37 |
| Market Cap | $0M |
| Exchange | NASDAQ |
| Country | US |
Valuation Multiples
| P/E Ratio | -0.03 |
| Price / Book | 1.11 |
| P/S | 0.41 |
| P/FCF | -0.02 |
| Dividend Yield | 0.00% |
Profitability
| Gross Margin | -151.47% |
| EBIT Margin | -2448.57% |
| EBITDA Margin | -2197.95% |
| Operating Margin | -2020.04% |
| Net Margin | -2449.04% |
Financial Health
| Current Ratio | 0.82 |
| Quick Ratio | 0.82 |
| Cash Ratio | 0.81 |
| Debt / Equity | 0.14 |
| Debt / Assets | 3.26% |
| Interest Coverage | -3967.77 |
| Piotroski F-Score | 3 |
| Altman Z-Score | -14.80 |
Per-Share Data
| Revenue per share | 0.33 |
| Book Value per share | 1.25 |
| Cash per share | 3.17 |
| FCF per share | -5.74 |
| Tangible Book Value per share | -0.65 |
| Dividend per share | 0.00 |
Analyst Consensus
| Strong Buy | 0 |
| Buy | 2 |
| Hold | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 2 |
| Avg rating (1-5) | 1.00 |
Related companies: BIAF · BIVI · BJDX · GLMD · HSCS · NDRA · SHPH
Explore sector: Healthcare · Medical - Diagnostics & Research
More sections of ISPC: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks